checkAd
    Startseite > Aktien > Journey Medical > Nachrichten
    Journey Medical
    Aktie
    ISIN: US48115J1097 WKN: A3C7KG SYM: DERM Land USA
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    5,5700
     
    USD
    +3,72 %
    +0,2000 USD
    Letzter Kurs 15.06.24 Nasdaq
    Geldkurs
    14.06.24
    5,5700
     
    USD
    9.300 STK
    Briefkurs
    14.06.24
    5,5900
     
    USD
    100 STK

    Journey Medical Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
    15.05.24 · globenewswire · Journey Medical
    Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
    13.05.24 · globenewswire · Journey Medical
    Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
    07.05.24 · globenewswire · Journey Medical
    Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
    01.05.24 · globenewswire · Journey Medical
    Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
    25.04.24 · globenewswire · Journey Medical
    Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
    21.03.24 · globenewswire · Journey Medical
    Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
    18.03.24 · globenewswire · Journey Medical
    Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
    15.03.24 · globenewswire · Journey Medical
    Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
    13.03.24 · globenewswire · Journey Medical
    Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
    11.03.24 · globenewswire · Journey Medical
    Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
    05.01.24 · globenewswire · Journey Medical
    Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
    02.01.24 · globenewswire · Journey Medical